SL PHARM
0020385.490.00% ( 0.00 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: SL PHARM(002038) the Revenue is 136.84 M (-18.98%);the EBIT is 36.64 M (+129.7%);the EPS is -0.08 (-300%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.14B18.98%
----
----
EBIT
0.04B129.67%
----
----
EPS
-0.08300.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf